Articles & Interviews

To mark Clinical trials day 2026, in a video interview for Applied Clinical Trials, Sam Hinsley, statistics manager a...

Sarah Tucker, Chief Operational Officer at Phastar, explores the evolution of Functional Service Provider (FSP) model...

Stephen Corson, Director of Operational Solutions at Phastar, explores the evolving role of contract research organiz...

Sam Hinsley, Statistics Manager at Phastar, shares practical insights into early phase clinical trial design in a new...

Real-world evidence (RWE) is no longer peripheral to drug development. Across regulatory, HTA and payer env...

Billy Amzal, PhD, Head of Strategic Consulting at Phastar, explores the first year of the EU Health Technology A...

To mark International Women’s Day 2026, a new article in Applied Clinical Trials authored by Vicky Marriott, Head of ...

To mark International Women’s Day 2026, a new article in PharmaLive, authored by Sarah Tucker, Chief Operating Office...

Billy Amzal, Head of Strategic Consulting at Phastar, and a Bayesian design expert and pioneer, explores the techniqu...

To mark Rare Disease Day 2026, a new article authored by Billy Amzal, Head of Strategic Consulting at Phastar, explor...

As innovative clinical trial designs gain traction, sponsors are looking more closely at how real-world data can be u...

As innovation reshapes drug development, industry leaders are looking ahead to how both preclinical discovery and cli...

As artificial intelligence reshapes clinical development, sponsors are rethinking what they need from their CRO partn...

As pharma looks ahead to 2026, greater regulatory and geopolitical clarity is expected to unlock delayed investment d...

As patient-centerd research continues to shape clinical trial design, electronic patient-reported outcomes (ePROs) ar...

Decentralized clinical trials (DCTs) continue to gain momentum as sponsors look to reduce participant burden, improve...

As APAC continues to embrace digital innovation, hybrid decentralized clinical trials (DCTs) are emerging as a practi...

As clinical trials grow increasingly complex, sponsors are turning to specialist CROs with the expertise to transform...

The adoption of advanced technological tools in clinical trials is accelerating as sponsors seek faster insights, str...

Outsourcing clinical trial activities to specialist data-focused CROs is growing rapidly, driven by the need for expe...

In this exclusive interview for World Pharma Today, Phastar’s Head of Strategic Consulting, Billy Amzal, shares his c...

In ACRP Clinical Researcher, Katie Dixon, Senior Statistician at Phastar, reflects on the transition from graduate to...

In an exclusive interview with the European Medical Journal, Graham Clark, CEO of Phastar, discusses the current stat...

As a follow-up to Clinical Trials Day 2025, with the theme of being “Powered By Purpose,” industry thought leaders sh...

In a recent Q&A with European Biopharmaceutical Review, Stephen Corson—Associate Director of Statistics and Techn...

In Giles Partington’s recent article for Pharmaceutical Outsourcing, the Phastar Principal Statistician explores how ...

In this exclusive Discover Pharma interview, Sarah Tucker, Chief Operating Officer at Phastar, shares how the CRO is ...

With major changes ahead for EU Health Technology Assessments (HTAs), including the introduction of joint clinical as...

In an exclusive feature for Contract Pharma, Phastar’s Head of Business Transformation and China General Manager, Pin...

With biotechs increasingly driving innovation in research and development, it is important for organizations to choos...

In an interview with The Clinical Trial Vanguard, Phastar CEO Graham Clark explores the evolving pharmaceutical lands...

Matthew Thompson, Associate Director, Statistical Programming at Phastar, authored a piece for Clinical Research News...

As we mark International Women’s Day 2025, Phastar is calling for accelerated action toward gender equality in data a...

On Rare Disease Day, we highlight the potential of Bayesian statistics to overcome recruitment challenges in rare dis...

At SCOPE 2025, Phastar CEO Graham Clark spoke with Applied Clinical Trials (ACT) about the future of clinical trial o...

Elisa Mansfield, Vice President of FSP at Phastar, contributed an article to Pharmaceutical Outsourcing discussing th...

Graham Clark, CEO at Phastar, spoke to PharmaVoice with his predictions on how AI and data science solutions will fur...

Graham Clark, CEO at Phastar, contributed to Clinical Research News on his predictions for clinical research in 2025....

Elisa Mansfield, Vice President FSP at Phastar contributed an article to European Pharmaceutical Contractor discussin...

Vicky Marriott, Head of Statistics at Phastar recently spoke with Outsourcing Pharma for its Women in Science feature...

Elisa Mansfield, Vice President, FSP at Phastar, contributed an article for the October issue of Applied Clinical Tri...

In Jack Jacobsen’s, Head of Data and Visual Analytics at Phastar, article with PM360 he explores how we can fully uti...

Phastar CEO, Graham Clark, was interviewed by the editor of Outsourcing Pharma at the DIA Global Annual Meeting earli...

“In data management, we are already seeing how AI can be used to power data review, risk management, and enable autom...

‘Statistics and the interpretation of statistical results are an important part of what researchers do and how health...

Wei Liu, Associate Director of Statistics at Phastar, recently co-authored a manuscript published in the Journal of t...

Phastar CEO, Graham Clark, recently spoke with Contract Pharma regarding the current trends, challenges, and growth d...

Ahead of DIA 2024, Phastar CEO Graham Clark spoke with Outsourcing Pharma about the major trends and challenges in th...

Ahead of the UK’s Mental Health Awareness Week, Peter Taylor, Phastar’s Senior Director and Global head o...

Giles Partington, Principal Statistician at Phastar, recently provided an article for Clinical Research News explaini...

In her article for BioSpectrumAsia, Professor Jennifer Visser-Rogers highlights ongoing gender inequality in the phar...

Professor Jennifer Visser-Rogers recently spoke with Outsourcing Pharma about her experience as a woman in science. A...

In this article for PharmaPhorum, Phastar’s Stephen Corson’s delves into the changing landscape of Health...

In his article for Applied Clinical Trials, Ping-Chung Chang’s highlights the rapid evolution of clinical trial...

In this article for PharmaTimes Magazine, Phastar’s Elisa Mansfield discusses the rising popularity and benefit...

In this article for ACRP Clinical Researcher, Professors Deborah Ashby and Jennifer Visser-Rogers discuss the challen...

Professor Deborah Ashby, Interim Dean of the Faculty of Medicine, Imperial College, recently presented Phastar&#...

In her article for Applied Clinical Trials, Professor Jennifer Visser-Rogers explores the evolving relationship betwe...

In this article for Clinical Research News, Andrew MacGarvey explores the transformative potential of big data analyt...

In this article for the Journal for Clinical Studies, Pamela Adede delves into the challenges posed by missing data i...

In this article for ICT Summer 2023, Professor Jennifer Visser-Rogers highlights the importance of collaborative effo...

In this article, Phastar’s Nicola Griffiths emphasizes the pivotal role of data science in managing the increas...

Phastar’s Carly Baker, Director of Clinical Data Management, and Alice Wang, Principal Data Scientist, recently...

Phastar statistician Ian Wadsworth had a research article published in Statistical Methods in Medical Research examin...